EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Next—Generation Diagnostic Technologies for Dengue Virus Detection: Microfluidics, Biosensing, CRISPR, and AI Approaches

Salim El Kabbani, Gameel Saleh iD

Sensors · 25.12.2025 · 26 (1) · 145

DOI: 10.3390/s26010145 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Sensors, online erschienen am 25.12.2025. Verfasst von Salim El Kabbani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Engineering, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia. Hauptthemen laut MEDLINE: Biosensing Techniques, Dengue Virus, Dengue, Microfluidics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saudi Institute of Health [Saudi NIH], Saudi National Institute of Health [Saudi NIH].

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue fever remains a major mosquito–borne disease worldwide, with over 400 million infections annually and a high risk of severe complications such as dengue hemorrhagic fever. The disease is prevalent in tropical and subtropical regions, where population density and limited vector control accelerate transmission, making early and reliable diagnosis essential for outbreak prevention and disease management. Conventional diagnostic methods, including virus isolation, reverse transcription polymerase chain reaction (RT–PCR), enzyme–linked immunosorbent assays (ELISA), and serological testing, are accurate but often constrained by high cost, labor–intensive procedures, centralized laboratory requirements, and delayed turnaround times. This review examines current dengue diagnostic technologies by outlining their working principles, performance characteristics, and practical limitations, with emphasis on key target analytes such as viral RNA; nonstructural protein 1 (NS1), including DENV–2 NS1; and host antibodies. Diagnostic approaches across commonly used biofluids, including whole blood, serum, plasma, and urine, are discussed. Recent advances in biosensing technologies are reviewed, including optical, electrochemical, microwave, microfluidic, and CRISPR–based platforms, along with the integration of artificial intelligence for data analysis and diagnostic enhancement. Overall, this review highlights the need for accurate, scalable, and field–deployable diagnostic solutions to support early dengue detection and reduce the global disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesDengue VirusDengueMicrofluidicsArtificial IntelligenceHumansRNA, Viral

Stichwörter der Autor:innen

CRISPR diagnosticsEIS)LSPRNS1 antigenSERS)artificial intelligence in viral detectionbiosensordengue virus detectionelectrochemical biosensors (DPVmicrofluidic lab–on–chipoptical biosensors (SPR

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Department of Biomedical Engineering, College of Engineering, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.

ORCID-Profile: Gameel Saleh

Förderung

  • Saudi Institute of Health [Saudi NIH]
  • Saudi National Institute of Health [Saudi NIH]

Zitieren

APA

El Kabbani, S., & Saleh, G. (2025). Next—Generation Diagnostic Technologies for Dengue Virus Detection: Microfluidics, Biosensing, CRISPR, and AI Approaches. Sensors, 26(1), 145. https://doi.org/10.3390/s26010145

Vancouver

El Kabbani S, Saleh G. Next—Generation Diagnostic Technologies for Dengue Virus Detection: Microfluidics, Biosensing, CRISPR, and AI Approaches. Sensors. 2025;26(1):145. doi:10.3390/s26010145

BibTeX
@article{ElKabbani2025,
  author = {El Kabbani, Salim and Saleh, Gameel},
  title = {Next—Generation Diagnostic Technologies for Dengue Virus Detection: Microfluidics, Biosensing, CRISPR, and AI Approaches},
  journal = {Sensors},
  year = {2025},
  volume = {26},
  number = {1},
  pages = {145},
  doi = {10.3390/s26010145}
}
Kostenlos starten →